Description
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a recombinant analogue of human IGF-1 featuring an N-terminal 13-amino-acid extension and an Arg substitution at position 3, reducing IGF-binding protein affinity and extending half-life. Research focuses on its role in muscle protein synthesis, satellite cell activation, glucose uptake, and anti-apoptotic signaling. Each vial contains 1mg lyophilized peptide. For research use only.
